Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2003

View Archived Issues

Clinical trial results for emtricitabine discussed at HIV meeting

Lipid-lowering effects described for YM-53601 in rodents

Roche to acquire IGEN

Oritavancin combination therapy in pneumococcal meningitis

CRL-42796 prevents carotid artery thrombosis in dogs

Improved pulmonary hypertension in sickle cell disease after oral L-arginine supplementation

Single dose of NN-2211 restores beta-cell responsiveness in type 2 diabetes

Olprinone and the management/prevention of fatigue in diaphragm contractility

Durable remission following treatment with i.m. alefacept in chronic plaque psoriasis

Adolor obtains North American rights to EpiCept's lidocaine patch

NicOx reviews first-half achievements

Vertex: Q2 accomplishments

Positive opinion handed down in Europe for new Synagis indication

Advate approved for bleeding episodes in patients with hemophilia A

CPMP recommends approval of Remicade for maintenance dosing in fistulizing CD

Approval of Xagrid recommended in Europe

Emend receives positive opinion from European CPMP

Wyeth patents cover novel 5-HT6 receptor ligands and potential uses

Novel antibacterial series described by Bayer

Preparation and use of inhibitors of the expression of VCAM-1 described by AtheroGenics

Compositions of dextrin sulfate for STDs claimed by ML Laboratories

Solid controlled-release formulations of known antidepressant

Icogen receives SBIR grant to fund identification of Alzheimer's therapeutic

Potential chemopreventive agents in development at SRI

Feasibility of PACT approach to solid tumor therapy demonstrated using CVS-10290

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...